NCT04061629

Minimal Occlusive Pressure With Cuffed ETTs: The Effect of 3 Different Sizes of cETT on Intracuff Pressure in Children

Nationwide Children's Hospital·ClinicalTrials.gov·device·Device trialCompleted
View on ClinicalTrials.gov
Study focus
Drug/Device/Intervention
Cuffed ETT
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Nationwide Children's Hospital
Location
Columbus, United States of America
Timeline & enrollment
Phase
N/A
Start date
Sep 18, 2017
End date
Jul 18, 2019
Enrollment
147 participants
Primary outcome

Number of participants that needed their ETT exchanged

Summary

Based on standard and historical practice, the predictive size of the endotracheal tube (ETT)
 to be used in children has been based on various formulas. However, no study has clearly
 compared these formulas to determine the optimal size of cuffed ETTs. Furthermore, they were
 developed when using a polyvinylchloride cuff and not the thinner polyurethane cuff which is
 in common clinical use today. Hence, the purpose of this current study is to evaluate which
 of the currently available formulas most closely predicts the appropriate size of cuffed ETT
 to be used based not only on the fit within the trachea, but more importantly the intracuff
 pressure after the cuff is inflated to seal the airway.

ICD-10 classifications
Surgical procedure, unspecifiedMedical procedure, unspecifiedOther surgical proceduresDuring unspecified surgical and medical careDuring unspecified surgical and medical care
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04061629
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT04061629 through Pure Global AI's free database. This phase not specified trial is sponsored by Nationwide Children's Hospital and is currently Completed. The study focuses on Surgical Procedure, Unspecified. Target enrollment is 147 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.